Bionano Genomics announced that Gulsen Kama will serve as its next Chief Financial Officer, CFO, effective September 11, 2023. Christopher Stewart, who held the position of CFO since September 2020, will stay on during the transition and then move into an advisory role. Kama was most recently Chief Financial Officer at Northern Data AG.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BNGO:
- Bionano Announces CFO Transition and Appointment of Gülsen Kama as Chief Financial Officer
- Bionano Genomics announces presentation of OGM utility at CGC 2023
- Bionano Announces Presentation of Optical Genome Mapping (OGM) Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting
- Bionano Genomics price target raised to $10 from $2 at BTIG
- Bionano Genomics reports Q2 revenue $8.7M, consensus $8.29M